Dr. Annunziata on Efforts to Prevent Gynecologic Cancers

Christina M. Annunziata, MD, PhD
Published: Tuesday, Aug 15, 2017



Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses focusing efforts to prevent gynecologic cancers.

Researchers need to think about treating patients earlier and determining how to prevent cancer from forming in the first place, she explains. There needs to be more examinations in high-risk groups and identify patients who are at risk for these gynecologic cancers—then work to help prevent a cancer diagnosis from occurring.

Progress is being made for therapies in the upfront and recurrent settings, but there needs to be more of a push in the prevention setting, she concludes.
SELECTED
LANGUAGE


Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses focusing efforts to prevent gynecologic cancers.

Researchers need to think about treating patients earlier and determining how to prevent cancer from forming in the first place, she explains. There needs to be more examinations in high-risk groups and identify patients who are at risk for these gynecologic cancers—then work to help prevent a cancer diagnosis from occurring.

Progress is being made for therapies in the upfront and recurrent settings, but there needs to be more of a push in the prevention setting, she concludes.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Community Practice Connections™: 2nd Annual International Congress on Oncology Pathology™Aug 31, 20191.5
Publication Bottom Border
Border Publication
x